About BioMedical SIG
The objective of the SIG is to increase the translation of research results into solutions in human healthcare.
The aim of the SIG is to create a place to propose and discuss burning topics related to the SIG objective.
Examples of topics that we would like to explore:
- Increase the awareness of researchers and KTOs in the bench-to-bedside process (maturation, clinical, regulatory, identification of a relevant need)
- Increase the attractivity of early-stage research to investors
- Transition research from preclinical to clinical
- Train researchers and KTOs to interact and negotiate with pharma and VCs
- Increase the sustainability of biotech/Pharma practices by drug repurposing and use of natural products
- A subset of members of the BioMed SIG would like to create a group of stakeholders active in those fields to:
- Identify main opportunities and challenges
- Generate guidelines (legal, IP, preclinical, clinical, regulatory) to be used as a reference
- Connect stakeholders with complementary needs to foster new collaborations
SIG Leader: David Silvestre
Are you interested in becoming a volunteer? Contact Arlyta Wibowo